Significant progress addressing CMC items noted in CRL
BLA resubmission remains on track for 2H 2024
https://www.globenewswire.com/news-release/2024/08/12/2928295/0/en/Abeona-Therapeutics-Reports-Second-Quarter-2024-Financial-Results-and-Concludes-Type-A-Meeting-with-FDA-to-Align-on-Upcoming-Pz-cel-BLA-Resubmission.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.